Search research articles
Contact Us
Filters
Showing results (21-30 of 542) with videos related to
Page
of 55
Sort By:
Diagnostic Microbiology and Infectious Disease
|
November 1, 1989
Susceptibility of clinical isolates of Candida spp. to terconazole and other azole antifungal agents
M A Pfaller, T Gerarden
Clinical Microbiology Reviews
|
July 1, 1988
Laboratory, clinical, and epidemiological aspects of coagulase-negative staphylococci
M A Pfaller, L A Herwaldt
Infectious Disease Clinics of North America
|
June 1, 1993
Antifungal susceptibility testing. Current state of technology, limitations, and standardization
M A Pfaller, M G Rinaldi
The Journal of Antimicrobial Chemotherapy
|
October 1, 1996
Standardization of antifungal susceptibility testing
M G Cormican, M A Pfaller
Journal of Clinical Microbiology
|
November 18, 1998
Variation in electrophoretic karyotype and antifungal susceptibility of clinical isolates of Cryptococcus neoformans at a university-affiliated teaching hospital from 1987 to 1994
M E Klepser, M A Pfaller
Diagnostic Microbiology and Infectious Disease
|
April 1, 1997
In vitro evaluation of contemporary beta-lactam drugs tested against viridans group and beta-haemolytic streptococci
M A Pfaller, R N Jones
Journal of Clinical Microbiology
|
October 2, 2002
Role of sentinel surveillance of candidemia: trends in species distribution and antifungal susceptibility
M A Pfaller, D J Diekema
The Journal of Antimicrobial Chemotherapy
|
November 7, 2000
MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) results from the Americas: resistance implications in the treatment of serious infections. MYSTIC Study Group (Americas)
M A Pfaller, R N Jones
Pharmacotherapy
|
August 15, 2001
In vitro antifungal susceptibility testing
H L Hoffman, M A Pfaller
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 13, 2000
In vitro activity of newer fluoroquinolones for respiratory tract infections and emerging patterns of antimicrobial resistance: data from the SENTRY antimicrobial surveillance program
R N Jones, M A Pfaller
Page
of 55
Search research articles
Search
Showing results (21-30 of 542) with videos related to
Sort By:
Page
of 55
Diagnostic Microbiology and Infectious Disease
|
November 1, 1989
Susceptibility of clinical isolates of Candida spp. to terconazole and other azole antifungal agents
M A Pfaller, T Gerarden
Clinical Microbiology Reviews
|
July 1, 1988
Laboratory, clinical, and epidemiological aspects of coagulase-negative staphylococci
M A Pfaller, L A Herwaldt
Infectious Disease Clinics of North America
|
June 1, 1993
Antifungal susceptibility testing. Current state of technology, limitations, and standardization
M A Pfaller, M G Rinaldi
The Journal of Antimicrobial Chemotherapy
|
October 1, 1996
Standardization of antifungal susceptibility testing
M G Cormican, M A Pfaller
Journal of Clinical Microbiology
|
November 18, 1998
Variation in electrophoretic karyotype and antifungal susceptibility of clinical isolates of Cryptococcus neoformans at a university-affiliated teaching hospital from 1987 to 1994
M E Klepser, M A Pfaller
Diagnostic Microbiology and Infectious Disease
|
April 1, 1997
In vitro evaluation of contemporary beta-lactam drugs tested against viridans group and beta-haemolytic streptococci
M A Pfaller, R N Jones
Journal of Clinical Microbiology
|
October 2, 2002
Role of sentinel surveillance of candidemia: trends in species distribution and antifungal susceptibility
M A Pfaller, D J Diekema
The Journal of Antimicrobial Chemotherapy
|
November 7, 2000
MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) results from the Americas: resistance implications in the treatment of serious infections. MYSTIC Study Group (Americas)
M A Pfaller, R N Jones
Pharmacotherapy
|
August 15, 2001
In vitro antifungal susceptibility testing
H L Hoffman, M A Pfaller
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 13, 2000
In vitro activity of newer fluoroquinolones for respiratory tract infections and emerging patterns of antimicrobial resistance: data from the SENTRY antimicrobial surveillance program
R N Jones, M A Pfaller
Page
of 55